Advanced Quantitative Benefit-Risk Assessment Methods in Decision Making on Medicines University of Bordeaux
The aim of this course is to be able to address the decision-making onmedicines by different stakeholders and how to apply advancedbenefit-risk assessment tools in this process.
- Post-graduated leve in Health or Life Sciences. - Language prerequisites: Non-native English speakers must provide acertificate proving a minimum of English B2 level (cf. Europass[http://europass.cedefop.europa.eu/]). - Computer and internet requirement.
- Assessment is a mix of continuous assessment. - Final assessment takes place by videoconference.
> This course conssits of the following parts: - Multi-criteria decision analysis. - Conjoint analysis. - Personalized benefit-risk assessment.
Recorded and live lectures, readings, home assignments, on-line quizzes, forums, wikis, live seminars.
Online Course Requirement
- Professionals: 3,000€/year. - Students: 1,500€/year. - No additional costs and no mobility required.Duration: 12 weeksLanguage of instruction: EnglishMode of delivery: E-learning
Site for Inquiry
Please inquire about the courses at the address below.
Contact person: Karine Palinkarine.firstname.lastname@example.org